By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sangamo BioSciences, Inc. 

501 Canal Boulevard
Suite A100
Richmond  California  94804  U.S.A.
Phone: 510-970-6000 Fax: 510-236-8951


Key Statistics

Ownership: Public

Web Site: Sangamo
Symbol: SGMO


Company News
Sangamo (SGMO) Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A 7/26/2016 10:05:08 AM
Sangamo (SGMO) Announces Participation At Upcoming Scientific Conferences In July 7/13/2016 8:02:31 AM
Sangamo (SGMO) Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS II 6/20/2016 6:36:02 AM
Sangamo (SGMO) Announces Presentation At The Jefferies 2016 Healthcare Conference 6/2/2016 7:53:44 AM
Sangamo (SGMO) CEO to Retire, GlaxoSmithKline (GSK)-Takeda (TKPYY) Exec to Take Helm 6/1/2016 5:47:15 AM
Sangamo (SGMO) Announces Participation At Upcoming Investor Conferences 5/10/2016 1:51:58 PM
Sangamo (SGMO) Presents Recent Developments From Research And ZFP Therapeutic Programs In Multiple Presentations At Annual Meeting Of The American Society Of Gene And Cell Therapy 5/9/2016 6:54:32 AM
Sangamo (SGMO) Reports First Quarter 2016 Financial Results 5/3/2016 7:57:21 AM
Sangamo (SGMO) Announces Presentation At The Deutsche Bank (DB) 41st Annual Health Care Conference 4/29/2016 7:56:30 AM
Sangamo (SGMO) Announces First Quarter 2016 Conference Call And Webcast 4/26/2016 7:47:44 AM